Skip to Main Content

Paper Details

Hypoxanthine is a pharmacodynamic marker of ischemic brain edema modified by glibenclamide.
Cell Rep Med
6
2022
Author NameAffiliation
Holly E HinsonOregon Health Sciences University
Kevin N ShethYale University School of Medicine
William T KimberlyDivision of Neurocritical Care and Center for Genomic Medicine, Massachusetts General Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2